Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS
· Delayed Price · Currency is USD
0.0110
0.00 (0.00%)
Aug 14, 2025, 8:00 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $13.67 thousand as of August 15, 2025. Its market cap has decreased by -99.81% in one year.
Market Cap
13.67K
Enterprise Value
-1.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 13.67K, a decrease of -99.96%. That is a compound annual growth rate of -82.29%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 13.67K | -99.56% |
Dec 31, 2024 | 3.07M | -18.06% |
Dec 29, 2023 | 3.75M | -48.56% |
Dec 30, 2022 | 7.29M | -81.86% |
Dec 31, 2021 | 40.18M | 24.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.93M |
Veradigm | 781.22M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 580.89M |
Glass House Brands | 567.91M |
American Oncology Network | 379.23M |
Northwest Biotherapeutics | 362.70M |
CytoDyn | 344.75M |